PERCEPTIVE ADVISORS LLC Portfolio

Auto-discovered 13F filer (Top-2000 by latest reported value).

SEC 13F CIK: 0001224962

What is a 13F filing? Who files one and when · What 13F filings can't tell you

MidHealth TiltHigh Turnover how tags are computed

Q1 2026 · 93 positions · Total reported value $4.76B · Top-10 concentration 50.5% · Updated 2026-10-18

Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR

Turnover: 55.5% · 26 new · 28 cut · 12 exited

Active Share (vs S&P 500): 98.8% · vs QQQ: 99.7% — share of the book that differs from index weights (higher = more active) · ranking

Est. Qtr Return (Q1 2026 → Q2 2026): +23.3% · vs SPY +8.4% · Prev Value $4.76B — last quarter positions weighted by this quarter price moves · ranking

In its Q1 2026 13F filing, PERCEPTIVE ADVISORS LLC disclosed 93 equity positions with a combined reported value of $4.76B. The filing implies a moderately concentrated portfolio: its ten largest positions account for 50.5% of reported value. HoldingsHub classifies the profile as Mid / Health Tilt / High Turnover.

The largest disclosed positions as of Q1 2026 were PRAX ($655.97M), ASND ($350.28M), ROIV ($229.51M). By sector, the heaviest allocations are Health Care 87.6%, Industrials 1.0%. Versus the prior quarter, allocation shifted toward Health Care (+8.3pp) and away from Other (-7.7pp).

Versus the prior quarter, PERCEPTIVE ADVISORS LLC opened 26 new positions, trimmed 28 and fully exited 12, a turnover rate of 55.5% of positions. The portfolio's overlap with the prior quarter was 54% of names.

The largest new positions opened in Q1 2026 were MRNA ($50.80M), IONS ($37.85M), DAWN ($37.64M).

Of the 12 positions fully exited versus the prior quarter, the largest were XBI ($134.12M), EXAS ($121.92M), ACLX ($95.59M).

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

New Positions (Q1 2026)

  • MRNA MODERNA INC · $50.80M
  • IONS IONIS PHARMACEUTICALS INC · $37.85M
  • DAWN DAY ONE BIOPHARMACEUTICALS I · $37.64M
  • DMRA DAMORA THERAPEUTICS INC COM SHS · $31.68M
  • RVMD REVOLUTION MEDICINES INC · $25.15M
  • DBVT DBV TECHNOLOGIES S A · $20.15M
  • STRO SUTRO BIOPHARMA INC · $17.82M
  • EVMN EVOMMUNE INC · $10.31M

Fully Exited (vs previous quarter)

  • XBI SPDR SERIES TRUST · prev qtr: $134.12M · history
  • EXAS EXACT SCIENCES CORP · prev qtr: $121.92M
  • ACLX ARCELLX INC · prev qtr: $95.59M
  • BSX BOSTON SCIENTIFIC CORP · prev qtr: $93.35M
  • FOLD AMICUS THERAPEUTICS INC · prev qtr: $90.72M
  • ATXS ASTRIA THERAPEUTICS INC · prev qtr: $84.89M
  • DHR DANAHER CORP DEL · prev qtr: $45.78M
  • CDTX CIDARA THERAPEUTICS INC · prev qtr: $36.48M

Insider Transactions (Form 4)

Latest PERCEPTIVE ADVISORS LLC buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

Transaction date Activity Security Shares Price Filing
2026-10-26 Opt exercise LeonaBio, Inc. 776,648 $0.00 SEC filing
2026-08-26 Buy Immatics N.V. 863,060 $8.69 SEC filing
2026-07-20 Award Freenome, Inc. 5,500,000 $10.00 SEC filing
2026-06-17 Award Kardigan, Inc. 20,706 — SEC filing
2026-04-17 Award MeiraGTx Holdings plc 555,555 $9.00 SEC filing

All insider transactions →

Fund Profile

Perceptive Advisors is an SEC-registered 13F filer based in New York, NY, United States. As of Q2 2026 it reported 107 US equity positions with a combined value of $6.30B. HoldingsHub carries 12 quarters of its filings (Q3 2023–Q2 2026).

Firm Snapshot

  • Headquarters: NEW YORK, NY, United States
  • SEC registration: 801-71841 (status: Approved), registered 2010-10-04
  • Regulatory AUM (Form ADV): $11.77B as of 2026-07-13
  • Client mix (by RAUM): pension and profit-sharing plans 100%
  • Manages 17 private funds, of which 6 hedge funds

Portfolio Structure

  • 107 positions · $6.30B reported value (Q2 2026)
  • Top 10 holdings = 47.5% of reported value
  • Largest position: PRAX (PRAXIS PRECISION MEDICINES I) at 10.8%
  • Average position size: $58.91M

Sector Tilt

  • Health Care 89.0%
  • Industrials 1.2%
  • Financials 0.1%
  • (classified holdings cover 90% of value)

Quarterly Activity

  • Q2 2026: 26 new, 28 added, 28 reduced, 12 exited
  • 25 positions unchanged

Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.

Sector Allocation

Health Care 87.6%
Other 11.4%
Sort by: Value Shares Weight Sector Change · CSV
# Shares Value Weight Allocation Change
1 2.04M $655.97M 13.78%
13.78%
Add
2 1.53M $350.28M 7.36%
7.36%
Add
3 8.29M $229.51M 4.82%
4.82%
Add
4 5.26M $208.88M 4.39%
4.39%
Add
5 2.37M $206.45M 4.34%
4.34%
Reduce
6 3.78M $190.83M 4.01%
4.01%
Add
7 1.58M $161.92M 3.40%
3.40%
Reduce
8 4.42M $139.36M 2.93%
2.93%
Reduce
9 1.23M $129.73M 2.73%
2.73%
Reduce
10 1.54M $129.65M 2.72%
2.72%
Reduce
11 4.14M $123.08M 2.58%
2.58%
Reduce
12 8.28M $115.16M 2.42%
2.42%
Hold
13 10.38M $102.17M 2.15%
2.15%
Hold
14 9.75M $97.02M 2.04%
2.04%
Add
15 1.44M $96.99M 2.04%
2.04%
Reduce
16 10.33M $89.31M 1.88%
1.88%
Hold
17 3.51M $87.89M 1.85%
1.85%
Add
18 11.91M $85.73M 1.80%
1.80%
Add
19 4.67M $84.65M 1.78%
1.78%
Add
20 7.43M $70.77M 1.49%
1.49%
Add
21 1.40M $68.45M 1.44%
1.44%
Reduce
22 1.64M $59.96M 1.26%
1.26%
Reduce
23 3.71M $57.52M 1.21%
1.21%
Add
24 1.00M $50.80M 1.07%
1.07%
New
25 12.59M $48.87M 1.03%
1.03%
Hold
26 10.10M $47.46M 1.00%
1.00%
Add
27 2.01M $45.18M 0.95%
0.95%
Add
28 5.83M $39.69M 0.83%
0.83%
Reduce
29 1.60M $39.68M 0.83%
0.83%
Reduce
30 85.42K $39.38M 0.83%
0.83%
Reduce
31 504.00K $37.85M 0.80%
0.80%
New
32 1.76M $37.64M 0.79%
0.79%
New
33 328.88K $36.62M 0.77%
0.77%
Reduce
34 2.29M $33.54M 0.70%
0.70%
Add
35 280.54K $33.05M 0.69%
0.69%
Reduce
36 170.00K $32.14M 0.68%
0.68%
Hold
37 1.22M $31.68M 0.67%
0.67%
New
38 6.74M $27.83M 0.58%
0.58%
Add
39 300.00K $27.71M 0.58%
0.58%
Add
40 377.54K $27.55M 0.58%
0.58%
Reduce
41 20.86M $27.12M 0.57%
0.57%
Reduce
42 658.44K $26.40M 0.55%
0.55%
Reduce
43 149.95K $25.34M 0.53%
0.53%
Add
44 258.60K $25.15M 0.53%
0.53%
New
45 6.43M $24.63M 0.52%
0.52%
Add
46 151.98K $24.23M 0.51%
0.51%
Reduce
47 1.45M $23.15M 0.49%
0.49%
Add
48 697.31K $23.10M 0.48%
0.48%
Reduce
49 1.17M $22.90M 0.48%
0.48%
Reduce
50 5.04M $21.41M 0.45%
0.45%
Reduce

FAQ

What did PERCEPTIVE ADVISORS LLC buy in 2026-Q1?

In its 2026-Q1 13F filing, PERCEPTIVE ADVISORS LLC reported 93 equity positions worth $4.76B in aggregate; its largest disclosed positions were PRAX ($655.97M), ASND ($350.28M), ROIV ($229.51M).

How large is PERCEPTIVE ADVISORS LLC's portfolio?

PERCEPTIVE ADVISORS LLC reported $4.76B of long equity holdings across 93 positions as of 2026-Q1. Top-10 holdings account for 50.5% of reported value.

What is PERCEPTIVE ADVISORS LLC's investment style?

HoldingsHub classifies the portfolio as Mid / Health Tilt / High Turnover, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/perceptive-advisors/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →